New pill tested to fight spreading prostate cancer in asian men

NCT ID NCT02294461

Completed Disease control Sponsor: Astellas Pharma Inc Source: ClinicalTrials.gov ↗

Summary

This study tested whether a daily pill called enzalutamide could slow down advanced prostate cancer that had spread and was no longer responding to standard hormone therapy. It involved 395 Asian men whose cancer had progressed but who had not yet received chemotherapy. Participants were randomly assigned to receive either enzalutamide or a placebo pill to compare how long it took for their cancer to worsen.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

CN00102

Shanghai, China
CN00103

Beijing, China
CN00104

Beijing, China
CN00105

Shanghai, China
CN00106

Beijing, China
CN00107

Hangzhou, China
CN00108

Shanghai, China
CN00109

Wuhan, China
CN00110

Nanjing, China
CN00111

Beijing, China
CN00112

Beijing, China
CN00113

Shanghai, China
CN00114

Beijing, China
CN00115

Beijing, China
CN00117

Nanjing, China
CN00118

Wenzhou, China
CN00119

Suzhou, China
CN00121

Changsha, China
CN00124

Xi'an, China
CN00125

Tianjin, China
CN00126

Shanghai, China
CN00127

Beijing, China
HK00402

Hong Kong, Hong Kong
KR00201

Incheon, South Korea
KR00202

Seongnam-si, South Korea
KR00203

Daegu, South Korea
KR00204

Seoul, South Korea
KR00205

Busan, South Korea
KR00206

Seoul, South Korea
KR00207

Busan, South Korea
KR00208

Seoul, South Korea
KR00209

Seoul, South Korea
KR00210

Seoul, South Korea
KR00211

Seoul, South Korea
KR00212

Cheongju-si, South Korea
KR00213

Daejeon, South Korea
KR00214

Anyang, South Korea
KR00215

Seoul, South Korea
TW00301

Taipei, Taiwan
TW00302

Taichung, Taiwan
TW00303

Taichung, Taiwan
TW00304

Taipei, Taiwan
TW00305

Taoyuan, Taiwan
TW00306

Taipei, Taiwan
TW00307

Tainan, Taiwan
TW00308

Tainan, Taiwan
TW00309

Kaohsiung City, Taiwan

Conditions

Explore the condition pages connected to this study.

PROGRESSIVE METASTATIC PROSTATE CANCER